Volume 7, Issue 4 (2021)                   Pharm Biomed Res 2021, 7(4): 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abbaspour kasgari H, Moradimajd P, Samaee H, Davoodi L. Healthy baby delivery from COVID-19 infected mother in Iran: process and protection. Pharm Biomed Res. 2021; 7 (4)
URL: http://pbr.mazums.ac.ir/article-1-369-en.html
1- Assistant Professor of clinical Pharmacy, Department of clinical pharmacy, School of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
2- Ph.D. Student of clinical pharmacy, pharmaceutical research center, Mazandaran University of Medical Sciences, Sari, Iran.
3- Assistant Professor of Infectious Disease, Department of Infectious Disease, School of Medicine, Antimicrobial Resistance Center. Ghaemshahr Razi hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract:   (247 Views)
Background: A pneumonia caused by novel coronavirus (SARS-CoV-2) emerged in Wuhan, Hubei Province in late December 2019. This virus spread rapidly and affecting 195 countries and territories around the world such as Iran. By March 22, 2020, this virus has affected more than 40000 people worldwide and caused more than 19000 deaths. Pregnant women are vulnerable group to viral infections because in pregnancy occurred partial immune suppression. Therefore, the COVID-19 epidemic may have rising global concern about consequences for pregnant women and fetus.
Case presentation: We have reported a 44 years old pregnant woman, 32-week gestation, with COVID-19 that she had healthy baby delivering with no evidence of COVID-19. The bad clinical outcomes including maternal mortality, stillbirth, spontaneous abortion and preterm delivery was not observed.
Conclusion: Viral pneumonia may has been high severity in pregnancy, because incidence physiological and immunological changes and shift from cell-mediated to humoral-mediated immunity. Vertical transmission COVID-19 from mother-to-child, short-term and long-term adverse effect on mother and newborn are still unclear and controversy.
 
     
Type of Study: case report | Subject: Clinical Pharmacy

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb